
Tuan H. Nguyen
Examiner (ID: 4878)
| Most Active Art Unit | 2813 |
| Art Unit(s) | 2813, 3991, 3992, 1104 |
| Total Applications | 1968 |
| Issued Applications | 1723 |
| Pending Applications | 53 |
| Abandoned Applications | 192 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20248344
[patent_doc_number] => 20250297213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => BRAIN ORGANOID CONTAINING OPTIC VESICLES GENERATED BASED ON H9 INDUCTION AND EYE-BRAIN FUSION CULTURE METHOD
[patent_app_type] => utility
[patent_app_number] => 19/227561
[patent_app_country] => US
[patent_app_date] => 2025-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 425
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19227561
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/227561 | BRAIN ORGANOID CONTAINING OPTIC VESICLES GENERATED BASED ON H9 INDUCTION AND EYE-BRAIN FUSION CULTURE METHOD | Jun 3, 2025 | Pending |
Array
(
[id] => 19543357
[patent_doc_number] => 20240360393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => CELL-CONTAINING VESSEL AND METHOD FOR PRODUCING NEURAL CELL-CONTAINING SPHEROID
[patent_app_type] => utility
[patent_app_number] => 18/762044
[patent_app_country] => US
[patent_app_date] => 2024-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18762044
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/762044 | CELL-CONTAINING VESSEL AND METHOD FOR PRODUCING NEURAL CELL-CONTAINING SPHEROID | Jul 1, 2024 | Pending |
Array
(
[id] => 20329717
[patent_doc_number] => 12459983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Engineered immune cells with receptor signal strength modulated by a hinge
[patent_app_type] => utility
[patent_app_number] => 18/650881
[patent_app_country] => US
[patent_app_date] => 2024-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 31038
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18650881
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/650881 | Engineered immune cells with receptor signal strength modulated by a hinge | Apr 29, 2024 | Issued |
Array
(
[id] => 19172495
[patent_doc_number] => 20240158469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 18/421142
[patent_app_country] => US
[patent_app_date] => 2024-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18421142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/421142 | COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS | Jan 23, 2024 | Pending |
Array
(
[id] => 19020525
[patent_doc_number] => 20240076696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRHYTHMOGENIC CARDIOMYOPATHY
[patent_app_type] => utility
[patent_app_number] => 18/503557
[patent_app_country] => US
[patent_app_date] => 2023-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18503557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/503557 | GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRHYTHMOGENIC CARDIOMYOPATHY | Nov 6, 2023 | Abandoned |
Array
(
[id] => 19389739
[patent_doc_number] => 20240279609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHOD FOR ISOLATING HUMAN DERMAL FIBROBLASTS
[patent_app_type] => utility
[patent_app_number] => 18/490714
[patent_app_country] => US
[patent_app_date] => 2023-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490714
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/490714 | METHOD FOR ISOLATING HUMAN DERMAL FIBROBLASTS | Oct 18, 2023 | Pending |
Array
(
[id] => 19300406
[patent_doc_number] => 20240228975
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => Methods for Differentiating Endothelial Cells
[patent_app_type] => utility
[patent_app_number] => 18/354212
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18354212
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/354212 | Methods for Differentiating Endothelial Cells | Jul 17, 2023 | Pending |
Array
(
[id] => 19300406
[patent_doc_number] => 20240228975
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => Methods for Differentiating Endothelial Cells
[patent_app_type] => utility
[patent_app_number] => 18/354212
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18354212
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/354212 | Methods for Differentiating Endothelial Cells | Jul 16, 2023 | Pending |
Array
(
[id] => 18893761
[patent_doc_number] => 20240009246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => CELLULAR-ANTIMICROBIAL COMBINATION COMPOSITION AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS OF JOINTS AND SOFT TISSUES
[patent_app_type] => utility
[patent_app_number] => 18/220689
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18220689
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/220689 | CELLULAR-ANTIMICROBIAL COMBINATION COMPOSITION AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS OF JOINTS AND SOFT TISSUES | Jul 10, 2023 | Pending |
Array
(
[id] => 19643158
[patent_doc_number] => 20240417678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => METHOD FOR THREE-DIMENSIONAL CELL CULTURE USING CELL GROWTH PROMOTING COLLOID AND MASS PRODUCTION OF HIGH-CONCENTRATION EXTRACELLULAR COMPOSITION USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/212339
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212339 | METHOD FOR THREE-DIMENSIONAL CELL CULTURE USING CELL GROWTH PROMOTING COLLOID AND MASS PRODUCTION OF HIGH-CONCENTRATION EXTRACELLULAR COMPOSITION USING THE SAME | Jun 20, 2023 | Pending |
Array
(
[id] => 18876681
[patent_doc_number] => 20240000050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/335613
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335613
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335613 | APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS | Jun 14, 2023 | Pending |
Array
(
[id] => 19763196
[patent_doc_number] => 12221469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Switch receptors using IL-9 signaling domains
[patent_app_type] => utility
[patent_app_number] => 18/328473
[patent_app_country] => US
[patent_app_date] => 2023-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 20307
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18328473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/328473 | Switch receptors using IL-9 signaling domains | Jun 1, 2023 | Issued |
Array
(
[id] => 19098075
[patent_doc_number] => 20240117303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 18/199415
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18199415
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/199415 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN MIDBRAIN DOPAMINERGIC NEURONS FROM NEURAL PROGENITOR CELLS | May 18, 2023 | Pending |
Array
(
[id] => 19203080
[patent_doc_number] => 20240174979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => CARTILAGE-DERIVED PROGENITOR CELL LINES
[patent_app_type] => utility
[patent_app_number] => 18/314803
[patent_app_country] => US
[patent_app_date] => 2023-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18314803
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/314803 | CARTILAGE-DERIVED PROGENITOR CELL LINES | May 8, 2023 | Pending |
Array
(
[id] => 18550771
[patent_doc_number] => 20230248771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => PLATELETS LOADED WITH ANTI-CANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/297581
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297581
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/297581 | PLATELETS LOADED WITH ANTI-CANCER AGENTS | Apr 6, 2023 | Pending |
Array
(
[id] => 18451920
[patent_doc_number] => 20230193199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Methods for Printing Functional Human Neural Tissue
[patent_app_type] => utility
[patent_app_number] => 18/057026
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057026
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057026 | Methods for Printing Functional Human Neural Tissue | Nov 17, 2022 | Pending |
Array
(
[id] => 18295793
[patent_doc_number] => 20230105479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/957998
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/957998 | OPTICALLY CONTROLLABLE FGFR STIMULATION USING WIRELESS CONTROLLED CELLULAR LIGHTING SYSTEM | Sep 29, 2022 | Pending |
Array
(
[id] => 18306413
[patent_doc_number] => 20230110313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => SWITCH RECEPTORS USING IL-9 SIGNALING DOMAINS
[patent_app_type] => utility
[patent_app_number] => 17/946894
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17946894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/946894 | SWITCH RECEPTORS USING IL-9 SIGNALING DOMAINS | Sep 15, 2022 | Abandoned |
Array
(
[id] => 18436350
[patent_doc_number] => 20230183644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/931440
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931440 | COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF | Sep 11, 2022 | Pending |
Array
(
[id] => 18469253
[patent_doc_number] => 20230203537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => STABLE PSEUDOTYPED LENTIVIRAL PARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/929816
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929816 | STABLE PSEUDOTYPED LENTIVIRAL PARTICLES AND USES THEREOF | Sep 5, 2022 | Pending |